Sentry Data Systems Inc., which makes competing software, can proceed with its claims that CVS violated Section 1 of the Sherman Act by tying its contract pharmacy services to software developed by Wellpartner Inc., a Florida federal judge ruled April 3.
The software products sold by Sentry and Wellpartner, which CVS acquired in 2017, help hospitals comply with the federal 340B program. The program created a “self-auditing” regime requiring close monitoring ...